Literature DB >> 15761778

PET: too much of a good thing? Does the plethora of choices impact on patient management?

Chaitanya Divgi, Neeta Pandit-Taskar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761778     DOI: 10.1007/s00259-005-1777-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

Review 1.  Spying on cancer: molecular imaging in vivo with genetically encoded reporters.

Authors:  Shimon Gross; David Piwnica-Worms
Journal:  Cancer Cell       Date:  2005-01       Impact factor: 31.743

2.  Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET.

Authors:  Perry W Grigsby; David G Mutch; Janet Rader; Thomas J Herzog; Imran Zoberi; Barry A Siegel; Farrokh Dehdashti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-02-01       Impact factor: 7.038

3.  Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases.

Authors:  S Truant; D Huglo; M Hebbar; O Ernst; M Steinling; F-R Pruvot
Journal:  Br J Surg       Date:  2005-03       Impact factor: 6.939

4.  Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.

Authors:  Joseph G Rajendran; David A Mankoff; Finbarr O'Sullivan; Lanell M Peterson; David L Schwartz; Ernest U Conrad; Alexander M Spence; Mark Muzi; D Greg Farwell; Kenneth A Krohn
Journal:  Clin Cancer Res       Date:  2004-04-01       Impact factor: 12.531

5.  Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.

Authors:  J E Mortimer; F Dehdashti; B A Siegel; J A Katzenellenbogen; P Fracasso; M J Welch
Journal:  Clin Cancer Res       Date:  1996-06       Impact factor: 12.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.